IBC Policy on Receipt and Transmission of Public Comments

(Adopted 01/23/2014)

1.0 Purpose

The purpose of this Institutional Biosafety Committee (IBC) policy is to provide information regarding receipt and transmission of public comments.

2.0 Scope

This policy applies to all members of the MU Institutional Biosafety Committee, MU Biological Safety Section, MU Principal Investigators, and MU employees and staff.

3.0 Related Documents

  • Universtiy of Missouri Institutional Biosafety Committee (IBC) Resource Book
  • U.S. Department of Health and Human Services, National Institutes of Health (NIH) - NIH Guidelines for Membership and Procedures, Section IV-B-2-a-(7).

4.0 Policy

The University of Missouri Institutional Biosafety Committee (IBC) encourages members of the public to submit comments to the IBC regarding any matter under the purview of the IBC. Upon receipt of any such comments, the IBC will prepare a response that will be approved by a vote of the IBC, and forward the public comments and IBC response to the U.S Department of Health and Human Services, National Institutes of Health (NIH) Office of Biotechnology Activities.

Public comments and IBC response shall be sent to:

Office of Biotechnology Activities
National Institutes of Health
6705 Rockledge Drive, Suite 750
MSC 7985 Bethesda, MD 20892-7985 (20817 for non-USPS mail)
Telephone: (301) 496-9838 Fax: (301) 496-9839